The aim of this study was to estimate prevalence of patients with asthma in Greenland according to age, gender and residence and to investigate the associated quality of care. The study was performed as a cross-sectional study with data extracted from the Greenlandic electronical medical record. A t…
The aim of this study was to estimate prevalence of patients with asthma in Greenland according to age, gender and residence and to investigate the associated quality of care. The study was performed as a cross-sectional study with data extracted from the Greenlandic electronical medical record. A total of 870 patients aged 12 years or above were diagnosed with asthma at the end of 2022, corresponding to a prevalence of 1.9%. In 2020, the total prevalence was 0.2%. The prevalence of patients aged 12 years or above with asthma was highest among patients in Nuuk (3.3%) compared with patients in the remaining parts of Greenland (1.1%). More women than men were diagnosed with asthma, and the prevalence increased with age from 20 to 59 years. The prevalence of current smokers was high among the asthma population. The quality of care was significantly higher among patients living in Nuuk for all process indicators compared with patients from the remaining parts of Greenland. The prevalence of asthma in Greenland is low compared to other comparable populations and might be underestimated. Initiatives supporting increased focus on diagnosing asthma are thus warranted.
Atuaruk
Ukioq:
2023
Sammisat:
Asthma; Prevalence; Quality of care
Atuagassiaq - atuakkap aqqa:
International Journal of Circumpolar Health
Atuagassiaq - ukioq pilersitaaffik - atuagaq:
82
DOI normu:
10.1080/22423982.2023.2195136
Ukioq:
2023
Sammisat:
COPD; Prevalence; Quality of care
Atuagassiaq - atuakkap aqqa:
International Journal of Environmental Research and Public Health
DOI normu:
10.3390/ijerph20095624
The aim was to test the internal consistency of the Greenlandic version of the COPD Assessment Test (CAT) questionnaire and to estimate the symptom burden in patients with chronic obstructive pulmonary disease (COPD) in Greenland using the CAT questionnaire. A Greenlandic version of the CAT question…
The aim was to test the internal consistency of the Greenlandic version of the COPD Assessment Test (CAT) questionnaire and to estimate the symptom burden in patients with chronic obstructive pulmonary disease (COPD) in Greenland using the CAT questionnaire. A Greenlandic version of the CAT questionnaire was developed including forward translation, reconciliation, backwards translation, and pilot test. Afterwards, a cross-sectional study of patients with COPD was conducted. The internal consistency assessed by the Cronbach α coefficient was 0.823 for the Greenlandic version of the questionnaire (n = 103). The CAT was negatively correlated to spirometry values and current smoking. In the cross-sectional study (n = 250), 81.1% of the patients experienced a high symptom burden (≥10). The main CAT score was 17 (range 0–38). The CAT was used in 9 out of 17 towns in Greenland. The Greenlandic version of the CAT questionnaire demonstrated a good internal consistency. We observed a high burden of symptoms associated with reduced lung function and active smoking status among patient diagnosed with COPD in Greenland. The questionnaire can be used in clinical practice for assessment of symptom burden in patients with COPD in Greenland and may help to increase focus on symptom control and quality of care.
Atuaruk
Ukioq:
2023
Sammisat:
COPD; Symptom burden; CAT questionnaire; COPD assessment test
Atuagassiaq - atuakkap aqqa:
International Journal of Circumpolar Health
Atuagassiaq - ukioq pilersitaaffik - atuagaq:
82
DOI normu:
10.1080/22423982.2023.2220476
Patientuddannelse i livsstilsrelaterede sygdomme i Grønland – et ph.d.-projekt
Ukioq:
2022
Sammisat:
Patientinddragelse; Interventionsforskning
Ataatsimiinneq - taaguut:
Nunamed 2022
Illoqarfik - ataatsimiinneq:
Nuuk
Nuna - ataatsimiinneq:
Grønland
Forekomsten af astma i Grønland og behandlingskvalitet – et tværsnitsstudie
Ukioq:
2022
Sammisat:
Astma; Forekomst; Behandlingskvalitet
Ataatsimiinneq - taaguut:
Nunamed 2022
Illoqarfik - ataatsimiinneq:
Nuuk
Nuna - ataatsimiinneq:
Grønland
Patientrapporterede oplysninger i klinisk praksis – Implementering af et grønlandsk spørgeskema til monitorering af KOL patienter
Ukioq:
2022
Sammisat:
PRO; Kronisk obstruktiv lungesygdom; KOL; Patientrapporterede oplysninger
Ataatsimiinneq - taaguut:
Nunamed 2022
Illoqarfik - ataatsimiinneq:
Nuuk
Nuna - ataatsimiinneq:
Grønland
Forekomst af patienter i Grønland, som bruger blodtrykssænkende medicin, samt en vurdering af vigtigheden af diagnose for behandlingskvaliteten – et tværsnitsstudie
Ukioq:
2022
Sammisat:
Hypertension; Forhøjet blodtryk; Forekomst; Behandlingskvalitet
Ataatsimiinneq - taaguut:
Nunamed 2022
Illoqarfik - ataatsimiinneq:
Nuuk
Nuna - ataatsimiinneq:
Grønland
Patient education in Greenland: Development and feasibility testing of an intervention to patients with type 2 diabetes and chronic obstructive pulmonary disease
Ukioq:
2022
Sammisat:
Patient education; Intervention development
Ataatsimiinneq - taaguut:
5th Annual Research Meeting 2022
Illoqarfik - ataatsimiinneq:
Aarhus
Nuna - ataatsimiinneq:
Denmark
Ukioq:
2022
Sammisat:
Hypertension; Forhøjet blodtryk; Forekomst; Behandlingskvalitet
Saqqummersinneqarfia - nittartakkap adressia:
Best Practice Nordic
Ukioq:
2022
Sammisat:
Artrose; Forekomst; Behandlingsmuligheder; Erfaringer; Grønland
Saqqummersinneqarfia - nittartakkap adressia:
Best Practice Nordic
Background: Adults with early-onset Type 2 Diabetes Mellitus (T2DM) are an emerging high-risk population who may experience social challenges related to diabetes management.
Objective: To explore the disclosure of T2DM and how disclosure affects diabetes self-management and the psychosocial adjustm…
Background: Adults with early-onset Type 2 Diabetes Mellitus (T2DM) are an emerging high-risk population who may experience social challenges related to diabetes management.
Objective: To explore the disclosure of T2DM and how disclosure affects diabetes self-management and the psychosocial adjustment to life with diabetes among adults with early-onset T2DM.
Methods: A qualitative study was conducted using Systematic Text Condensation (STC). Data was derived from semi-structured interviews with 15 individuals with T2DM ≤ 46 years (10 women and 5 men) recruited from diverse settings using purposeful sampling.
Results: Most informants disclosed their diabetes to a close relative shortly after receiving the diagnosis. This led to immediate emotional support and overall positive disclosure experiences. However, informants often hesitated to disclose their condition to others due to shame, fear of negative judgement or social exclusion. Over time, the majority of informants became more open about their condition, which often resulted in emotional and practical self-management support. Those most reluctant to disclosing their diabetes struggled with shame and negative diabetes-related emotions, which had negative effects on their diabetes self-management.
Conclusion: Disclosure of T2DM seemed important for the social, emotional and practical management of diabetes among adults with early-onset T2DM. The disclosure was most often accompanied by feelings of shame and fear of condemnation. Professional guidance to support disclosure and interventions to address stigma may improve well-being and diabetes self-management in this population.
Atuaruk
Ukioq:
2020
Sammisat:
Type 2 diabetes; Disclosure; Self-management; Qulitative study; Early-onset type 2 diabetes; Psychosocial adjustment
Atuagassiaq - atuakkap aqqa:
The Open Diabetes Journal
Atuagassiaq - ukioq pilersitaaffik - atuagaq:
10
DOI normu:
10.2174/1876524602010010011
Purpose: We investigated risk of myocardial infarction (MI) associated with the content of linoleic acid (LA) in adipose tissue, a biomarker of long-term dietary intake of LA and a marker of endogenous LA exposure.
Methods: Between 1993 and 1997, 57,053 middle-aged subjects were included in the Dan…
Purpose: We investigated risk of myocardial infarction (MI) associated with the content of linoleic acid (LA) in adipose tissue, a biomarker of long-term dietary intake of LA and a marker of endogenous LA exposure.
Methods: Between 1993 and 1997, 57,053 middle-aged subjects were included in the Danish Diet, Cancer and Health cohort. We performed a case–cohort study that included a random sample of the full cohort (n=3167) and all incident MI cases appearing during 16 years of follow-up (n=2819). Information on incident MI cases was obtained by linkage with Danish nationwide registries. Adipose tissue biopsies were taken from the buttocks of the participants, and their fatty acid composition was determined using gas chromatography. HRs (hazard ratios) with 95% confidence intervals (CIs) were used to describe the associations between content of LA in adipose tissue and the risk of MI. HRs were calculated using weighted Cox proportional hazards regression with robust variance.
Results: After adjustment for established risk factors of MI, adipose tissue content of LA was not associated with the risk of MI in men and women combined (quintiles 5 versus 1, HR, 1.03 (95% CI, 0.85–1.25), P-trend=0.970) or in men and women separately (quintiles 5 versus 1, HR, 1.05 (95% CI, 0.83–1.33), P-trend=0.871 and quintiles 5 versus 1, HR, 0.99 (95% CI 0.72–1.37), P-trend=0.928, respectively). Investigating the association between LA and MI with a shorter, 5- or 10-year duration of follow-up provided similar results.
Conclusion: Content of LA in adipose tissue was not associated with the risk of MI.
Atuaruk
Allattoq:
Maja Hykkelbjerg Nielsen; Morten Frydenberg; Christian Sørensen Bork; Stine Krogh Venø; Anne Tjønneland; Erik Berg Schmidt; Kim Overvad; Marianne Uhre Jakobsen
Sammisat:
Adipose tissue; Coronary heart disease; Linoleic acid; Myocardial infarction; N-6 fatty acids; Omega-6 fatty acids
Atuagassiaq - atuakkap aqqa:
European Journal of Nutrition
DOI normu:
10.1007/s00394-021-02526-y
This study aimed to estimate the age- and sex specific prevalence of patients using antihypertensive medication in Greenland, and compared the quality of care between patients with and without a diagnosis for hypertension. The study was a cross-sectional study comparing patients using antihypertensi…
This study aimed to estimate the age- and sex specific prevalence of patients using antihypertensive medication in Greenland, and compared the quality of care between patients with and without a diagnosis for hypertension. The study was a cross-sectional study comparing patients using antihypertensive medication in 2020 (6,629 patients) and 2021 (7,008 patients), respectively. For data from 2021, patients with a medical diagnosis code were identified. Data was obtained from the Greenlandic electronic medical record. The population of Greenland was used as background population. Quality of care was evaluated based on suggested indicators by international guidelines and goals from Steno Diabetes Centre Greenland. The prevalence of patients aged ≥20 years using antihypertensive medication had increased from 16.7% in 2020 to 17.5% in 2021. The prevalence increased by age and was higher among women compared to men. In 2021, the prevalence of patients aged ≥20 years with a medical diagnosis code for hypertension was 7.9%. The use of antihypertensive medication in Greenland is common. The associated quality of care was low. However, process indicators were significantly improved when patients had a medical diagnosis code. Future focus must be on initiating initiatives ensuring that more patients are registered with a medical diagnosis code.
Atuaruk
Sammisat:
Hypertension; Prevalence; Quality of care; Greenland; Inuit
Atuagassiaq - atuakkap aqqa:
International Journal of Circumpolar Health
Atuagassiaq - ukioq pilersitaaffik - atuagaq:
81
DOI normu:
10.1080/22423982.2022.2110675